Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD

NCT07198113 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT07198113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07198113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
September 30, 2028
Enrollment
1,100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, ulcerative colitis, pediatric